Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Cem Griffiths"'
Publikováno v:
BRITISH JOURNAL OF DERMATOLOGY
Background: Psoriasis is associated with significant morbidity, which negatively impacts upon quality of life. Sleep disturbance is reported to be common in patients with psoriasis and is associated with physical and psychological variables, although
Publikováno v:
British Journal of Dermatology. 180:1281-1283
Autor:
Richard B. Warren, Niall J Davison, A. D. Burden, Kathleen McElhone, Brian Kirby, Katherine Payne, K.J. Mason, Catherine H. Smith, Cem Griffiths
Publikováno v:
Davison, N J, Warren, R B, Mason, K J, McElhone, K, Kirby, B, Burden, A D, Smith, C H, Payne, K & Griffiths, C E M 2017, ' Identification of factors that may influence the selection of first-line biologic therapy for people with psoriasis : a prospective, multi-centre cohort study ', British Journal of Dermatology, vol. 177, no. 3, pp. 828-836 . https://doi.org/10.1111/bjd.15551
BACKGROUND: The Psoriasis Stratification to Optimise Relevant Therapy (PSORT) consortium has a collective aim to develop a prescribing algorithm to help stratify eligible psoriasis patients to the most appropriate biologic treatment. To facilitate th
Autor:
Rachel E.B. Watson, Matiss Ozols, Michael J. Bell, Cem Griffiths, Sarah A. Hibbert, Michael J. Sherratt
Publikováno v:
British Journal of Dermatology. 176:e40-e81
Autor:
Kathleen McElhone, Cem Griffiths, I.Y.K. Iskandar, C. M. Owen, Ian Evans, Catherine H. Smith, Nick J. Reynolds, A. D. Burden, Richard B. Warren, Darren M. Ashcroft
Publikováno v:
Iskandar, I Y K, Ashcroft, D M, Warren, R B, Evans, I, McElhone, K, Owen, C M, Burden, A D, Smith, C H, Reynolds, N J & Griffiths, C E M 2017, ' Patterns of biologic therapy use in the management of psoriasis : cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) ', British Journal of Dermatology, vol. 176, pp. 1297-1307 . https://doi.org/10.1111/bjd.15027
BACKGROUND: Treatment modifications, including dose-escalations, dose-reductions, switches, discontinuations and restarts of biologics may be necessary in the management of psoriasis but the patterns of usage are incompletely defined.OBJECTIVES: To e
Autor:
Carsten Flohr, Cem Griffiths, Matthias Augustin, Lucia Naldi, Darren M. Ashcroft, Tamar Nijsten, J. M. Van der Walt
Publikováno v:
Griffiths, C, Van der Walt, J M, Ashcroft, D M, Flohr, C, Naldi, L, Nijsten, T & Augustin, M 2017, ' The global state of psoriasis disease epidemiology : A workshop report ', British Journal of Dermatology, vol. 177, no. 1, pp. e4-e7 . https://doi.org/10.1111/bjd.15610
The British Journal of Dermatology
British Journal of Dermatology, 177(1), E4-E7. Wiley-Blackwell Publishing Ltd
The British Journal of Dermatology
British Journal of Dermatology, 177(1), E4-E7. Wiley-Blackwell Publishing Ltd
Summary The International Psoriasis Council, a global nonprofit organization dedicated to innovation across the full spectrum of psoriasis, led a symposium to discuss the current state of psoriasis epidemiology and to introduce the vision and develop
Publikováno v:
The British Journal of Dermatology
Autor:
Nicola Reynolds, Kathleen McElhone, A. D. Burden, Cem Griffiths, Mark Lunt, Richard B. Warren, Z.Z.N. Yiu, Darren M. Ashcroft, Anthony Ormerod, I.Y.K. Iskandar, Catherine H. Smith, Jonathan Barker
Publikováno v:
British Journal of Dermatology. 173:510-518
Background The British Association of Dermatologists Biologic Interventions Register (BADBIR) is a prospective, observational cohort designed to assess the long-term safety of biologic and conventional systemic therapies used for adults with moderate
Autor:
Cem Griffiths, R Parslew, M. Donaldson, Ali Alsharqi, Michael R. Barnes, A.C. Foulkes, Richard B. Warren, Daniel F. Carr, Munir Pirmohamed, N. J. Reynolds
Publikováno v:
British Journal of Dermatology. 171:e105-e173
Autor:
Rainer Hinz, G. Holland, Zhangjie Su, Alexander Gerhard, H.J.A. Hunter, Cem Griffiths, Stephen J. Hopkins, Peter S. Talbot, C.E. Kleyn
Publikováno v:
British Journal of Dermatology. 175:1082-1084
Psoriasis is a chronic, immune-mediated inflammatory skin disease affecting approximately 2% of the population.1 It is associated with multiple comorbidities including arthritis, cardiovascular disease and the metabolic syndrome and as such is widely